SYNJ2 and early-onset autosomal dominant Alzheimer disease: Dysregulation of SYNJ2 has been implicated in several neurodevelopmental and neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder [33], conditions often associated with synaptic dysfunction, chronic inflammation, and impaired plasticity.